 1. To determine the change in pain from day 0 to day 28 with scrambler therapy in patients with pancreas cancer pain. Question 3 of the Modified Brief Pain Inventory. This endpoint serves to get preliminary information on the effect size for planning future larger, phase III studies comparing to splanchnic or celiac nerve blocks. The primary measurement tool for pain will be the Brief Pain Inventory BPI. 